November 2017 Issue - Endovascular Today

Table of Contents

Issue

November 2017

TEVAR

Strategizing Success

Supplement

Zenith® Fenestrated

The first FDA-approved option for treating ≥ 4mm short-necked infrarenal AAA.

In This Issue

Guest Chief Medical Editors' Page

TEVAR: Strategizing Success

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

Cover Stories

Classification of Aortic Pathologies

A brief review of thoracic aortic aneurysms and acute aortic syndrome, including classic aortic dissection, intramural hematoma, and penetrating aortic ulcer.

By Sharif H. Ellozy, MD

Preoperative Risk Assessment for Optimal TEVAR Outcomes

Evaluating which imaging, risk stratification, and system-specific options to consider before thoracic endovascular aortic repair.

By Tristan R. A. Lane, PhD, BSc, MBBS, MRCS; Sadie Syed, MD, MBBS, FRCA; Richard Gibbs, MD, MBChB, FRCS; and Colin D. Bicknell, MD, FRCS

Thoracic Aortic Aneurysms: At What Size Should We Intervene?

Key factors to consider when selecting patients for TAA repair.

By Robert J. Hinchliffe, MD, FRCS, and Paul Hollering

Ask the Experts: When and How Do You Survey a Small TAA?

Experts discuss how the definition of small AAAs and TAAs has changed in the past decade and how best to treat them.

With Timur P. Sarac, MD; Dittmar Böckler, MD, PhD; Moritz S. Bischoff, MD; Katrin Meisenbacher, MD; and Ian M. Loftus, MD, FRCS

Identifying the Appropriate Thoracic Device Size

How to correctly size a thoracic device in diameter, landing zone, and length.

By Michael E. Barfield, MD, and Thomas S. Maldonado, MD

The Aberrant Vertebral Artery With Aortic Arch Pathology

A discussion of the indications for revascularization and technical tips for preservation.

By Tareq M. Massimi, MD, and Edward Y. Woo, MD

TEVAR and Reintervention: How to Manage Endoleaks and False Lumen Perfusion

Treatment approaches for thoracic aortic aneurysm and thoracic aortic dissection failures.

By Zachary Kostun, MD, and Manish Mehta, MD, MPH

Ask the Experts: What Is Your Protocol for Following Patients After TEVAR?

Expects comment on their approach to surveillance for patients with aneurysmal disease versus aortic dissection.

With Rajesh K. Malik, MD, FACS, RPVI; Tilo Kölbel, MD, PhD; Patrick Kelly, MD; and James F. McKinsey, MD

Featured Program

November 2017 Supplement

Zenith® Fenestrated

The first FDA-approved option for treating ≥ 4mm short-necked infrarenal AAA.

In This Issue

November 2017 Supplement

Most Read Articles